PRTA
Prothena Corporation plc
NASDAQ · Healthcare · Biotechnology · IE
$9.82
+2.29%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.98x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.17x
- Net debt / EBITDA
- 6.84x
Liquidity & coverage
- Current ratio
- 25.05x
- Quick ratio
- 25.05x
- Cash ratio
- 24.72x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $280.4M
Cash & dividend
- FCF / debt
- -8.68x
- Cash flow / debt
- -8.59x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026